A Novel Molecular Cytogenetic Finding of Leiomyomatosis Peritonealis Disseminata.

Yan-Ting Wu,Yan Wu,Song-Chang Chen,Feng Zhou,Chun-Bo Yang,Zhen-Wei Xie,Chen-Ming Xu,Hang-Mei Jin
DOI: https://doi.org/10.1159/000381262
2015-01-01
Gynecologic and Obstetric Investigation
Abstract:Background: Leiomyomatosis peritonealis disseminata (LPD) is a rare disease characterised by the subperitoneal proliferation of smooth muscle cells that form benign nodules. A few studies have aimed to reveal the pathogenesis of LPD without reaching a clear explanation. Methods: Karyotype analysis and array-comparative genomic hybridization (aCGH) of a human LPD case were performed to evaluate the role of chromosomal abnormalities in LPD pathogenesis. Results: The LPD nodules showed a 45, XX, del(7p), t(11; 17) (q23;q25),-22 de novo karyotype, and the aCGH analysis confirmed these deletions at 7p22.3-p12.1 (1,862,362-52,766,911 bp) and 22q11.23-q13.33 (21,973,915-49,265,116 bp) with lengths of 50.9 Mb and 27.3 Mb, respectively. Conclusion: In this study, we described two large novel aberrations - deletions in chromosome 7 and 22 - that might play an important role in LPD disease. These findings might contribute to new insights to unravel the pathogenesis of LPD and develop further clinical treatments.
What problem does this paper attempt to address?